Management of Lung Cancer with Concomitant Cardiac Disease

Powell, Benjamin C.; Bolton, William D.

doi:10.1016/j.thorsurg.2017.08.008

Cited by 9 publications

(17 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In combined CAD and LC, treatment options are: 1) PCI followed by lung resection; 2) staged CABG and lung resection; 3) simultaneous CABG and lung resection [ 3 ] . CABG can be performed with or without CPB.…”

Section: Discussionmentioning

confidence: 99%

“…As the elderly population increases, there are an increasing number of patients who are diagnosed with lung cancer (LC) and have concurrent heart disease requiring surgical intervention. According to The Society of Thoracic Surgeons database, 20.9% of the patients undergoing pulmonary resection for LC have coronary artery disease (CAD); however, only 0.4-0.5% of these patients required coronary artery bypass grafting (CABG) [ 1 - 3 ] .…”

Section: Introductionmentioning

confidence: 99%

“…Percutaneous coronary intervention (PCI), followed by lung resection, required months of delay in tumor management due to the use of dual antiplatelet therapy (DAPT) and stent thrombosis after cessation of DAPT is the main problem. In staged operations, the cardiac procedure was performed first and after a recovery period of 2 to 8 weeks, pulmonary resection was performed [ 3 ] . Disadvantages of the staged approach are complications arising from the consequent administration of anesthesia, risk of disease progression due to delayed treatment, patients' anxiety, cost of treatment, hospital stay [ 3 , 4 ] .…”

Section: Introductionmentioning

confidence: 99%

“…In staged operations, the cardiac procedure was performed first and after a recovery period of 2 to 8 weeks, pulmonary resection was performed [ 3 ] . Disadvantages of the staged approach are complications arising from the consequent administration of anesthesia, risk of disease progression due to delayed treatment, patients' anxiety, cost of treatment, hospital stay [ 3 , 4 ] . On the other hand, simultaneous procedures have a longer operation time and lead to increased risks of operative bleeding, tissue edema and immunosuppression due to cardiopulmonary bypass (CPB) [ 3 - 6 ] .…”

Section: Introductionmentioning

confidence: 99%

“…Off-pump coronary artery bypass grafting (OPCABG) technique has been gaining popularity since the last decade, because it does not require CPB. Recently, several papers showed that simultaneous OPCABG and lung resections may be safe and feasible in combined CAD and LC [ 3 , 5 - 8 ] . We presented our patients who underwent simultaneous surgery for concurrent CAD and LC in our clinic.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease

Yeginsu¹,

Vayvada²,

Karademir³

et al. 2018

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

IntroductionOptimal surgical approach for the treatment of resectable lung cancer accompanied by coronary artery disease (CAD) remains a contentious issue. In this study, we present our cases that were operated simultaneously for concurrent lung cancer and CAD.MethodsSimultaneous off-pump coronary artery bypass surgery (OPCABG) and lung resection were performed on 10 patients in our clinic due to lung cancer accompanied by CAD. Demographic features of patients, operation data and postoperative results were evaluated retrospectively.ResultsMean patient age was 63.3 years (range 55-74). All patients were male. Six cases of squamous cell carcinoma, three of adenocarcinoma and one case of large cell carcinoma were diagnosed. Six patients had single-vessel CAD and 4 had two-vessel CAD. Three patients underwent OPCABG at first and then lung resection. The types of resections were one right pneumonectomy, three right upper lobectomies, one right lower lobectomy, three left upper lobectomies, and two left lower lobectomies. Reoperation was performed in one patient due to hemorrhage. One patient developed intraoperative contralateral tension pneumothorax. One patient died due to acute respiratory distress syndrome at the early postoperative period.ConclusionSimultaneous surgery is a safe and reliable option in the treatment of selected patients with concurrent CAD and operable lung cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease

Yeginsu¹,

Vayvada²,

Karademir³

et al. 2018

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

Concomitant Resection of Left Ventricular Hemangioma and Lung Cancer With Ground-Glass Opacity

Tsukioka

Kono

Takahashi

et al. 2020

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

Simultaneous Minimally Invasive Coronary Artery Bypass Grafting and Lung Resection

Lianyong,

Pengkai,

Xuefeng

et al. 2023

Thorac Cardiovasc Surg

View full text Add to dashboard Cite

Background: The best surgical treatment strategy for coexisting coronary artery disease and lung cancer remains controversial. This study analyzed the safety and efficacy of a simultaneous minimally invasive procedure for patients with coronary artery disease and lung cancer. Methods: Patients who underwent simultaneous minimally invasive off-pump coronary artery bypass grafting and lung resection from January 2016 to December 2021 were retrospectively analyzed. The procedure was performed in the fourth intercostal space through a small left anterolateral mini-thoracotomy. Harvesting of the left internal thoracic artery (LIMA) and sewing of the anastomoses were performed under direct vision. Lung resections were performed with or without the assistance of a thoracoscope. Results: Sixteen patients were included with a mean age of 67.13±10.61 years. Procedural success occurred in all patients with a mean operative time of 366.88±94.48 min. All patients received at least one coronary artery bypass LIMA graft. Pneumonectomy, lobectomy, segment resection, and wedge resection were performed in 1 (6.25%), 8 (50%), 2 (12.5%) and 5 (31.25%) patients, respectively. There were no perioperative deaths or new myocardial infarctions. Complications included 1 case of postoperative bleeding, 2 lung infections, 2 cases of atelectasis, 1 case of pleural effusion and 1 case of cardiac arrhythmia. All the patients were followed up for 1-57 months, cancer recurrence occurred in 2 patients, and one patient died. The remaining patients showed no evidence of tumor recurrence or myocardial infarction. Conclusions: Simultaneous minimally invasive procedure is safe and effective for select patients with coronary artery disease and lung cancer.

show abstract

Management of Lung Cancer with Concomitant Cardiac Disease

Cited by 9 publications

References 41 publications

Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease

Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease

Concomitant Resection of Left Ventricular Hemangioma and Lung Cancer With Ground-Glass Opacity

Simultaneous Minimally Invasive Coronary Artery Bypass Grafting and Lung Resection

Contact Info

Product

Resources

About